Study to Evaluate the Safety and Anti-tumor Activity of SCC244
Status:
Unknown status
Trial end date:
2021-10-01
Target enrollment:
Participant gender:
Summary
This study evaluates the Safety, Tolerability, Pharmacokinetics, and Anti-tumor Activity of
SCC244 in patients with advanced solid tumors with c-Met Alterations.